Location History:
- Shiga, JP (1987)
- Otsu, JP (1986 - 1993)
Company Filing History:
Years Active: 1986-1993
Title: Masao Tohno: Innovator in Pharmaceutical Chemistry
Introduction
Masao Tohno is a distinguished inventor based in Otsu, Japan, known for his significant contributions to pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to developing compounds with therapeutic applications. His work primarily focuses on anti-inflammatory and analgesic agents, which have a profound impact on medical treatments.
Latest Patents
Among his latest patents are the biphenylylpropionic acid derivatives, which are designed to exhibit excellent anti-inflammatory, analgesic, and antipyretic activities. These compounds are characterized by their unique structural formula, where R represents an alkylcarbonyloxyalkyl group or an alkenylcarbonyloxyalkyl group. The derivatives are noted for their lack of irritation, rapid and long-acting effects, and high safety margins. Additionally, Tohno has developed an ophthalmic preparation that includes a fat emulsion containing flurbiprofen or its derivatives as active ingredients, further demonstrating his expertise in the field.
Career Highlights
Throughout his career, Masao Tohno has worked with notable companies such as Kaken Pharmaceutical Company, Ltd. and The Green Cross Corporation. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical innovations.
Collaborations
Tohno has collaborated with esteemed colleagues, including Katsuhiro Uchida and Makoto Okumura, enhancing the scope and impact of his research. These partnerships have played a crucial role in the development of his patented compounds.
Conclusion
Masao Tohno's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of effective therapeutic agents, making a significant difference in healthcare.